Bioorganic and Medicinal Chemistry p. 142 - 159 (2007)
Update date:2022-08-02
Topics:
Pryde, David C.
Cook, Andrew S.
Burring, Denise J.
Jones, Lyn H.
Foll, Stephanie
Platts, Michelle Y.
Sanderson, Vivienne
Corless, Martin
Stobie, Alan
Middleton, Donald S.
Foster, Laura
Barker, Laura
Van Der Graaf, Piet
Stacey, Peter
Kohl, Christopher
Coggon, Sara
Beaumont, Kevin
A series of substituted glutaramides were synthesised using Candoxatrilat 1 as a lead and evaluated for potency against neutral endopeptidase (NEP) as a potential treatment for female sexual arousal disorder (FSAD). In this paper, we describe studies in which we were able to increase NEP activity substantially over the levels reported for previous compounds from this programme by appropriate substitution in both the P1′ and P2′ regions. Optimisation led to the 4-chlorophenpropylamide S-30 which was selected as a candidate for further study.
View MoreContact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Arshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
website:http://www.amadischem.com
Contact:86-571-89925085
Address:Watts Cosine.No.166.Xiangmao Road.
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
Doi:10.1080/00397910902767491
(2009)Doi:10.1039/b908638b
(2009)Doi:10.1039/b910921h
(2009)Doi:10.1002/jhet.5570390529
(2002)Doi:10.1021/acs.orglett.8b03067
(2018)Doi:10.1016/j.tetlet.2009.07.038
(2009)